MBAML
RNAM

Marble Bar Asset Management LLP’s Avidity Biosciences RNAM Stock Holding History

Marble Bar Asset Management LLP’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,777
Closed -$417K – 33
2025
Q4 		$417K Buy
+5,777
New +$373K 9.66% 4

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Marble Bar Asset Management LLP's RNAM Position: Q1 2026 in Review

Marble Bar Asset Management LLP sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 5,777 shares — an estimated $417K sold.

Marble Bar Asset Management LLP first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $417K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Marble Bar Asset Management LLP reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Marble Bar Asset Management LLP sold 5,777 Avidity Biosciences shares in Q1 2026, an estimated $417K.
  • Marble Bar Asset Management LLP first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Marble Bar Asset Management LLP's Avidity Biosciences position peaked at $417K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Marble Bar Asset Management LLP's 13F filing for Q1 2026, filed 14 May 2026.